When private equity evaluates a hospital group, what truly moves the EBITDA multiple — and what is just digital theatre?

In this episode, we go deep with Arvind Sivaramakrishnan, CTO for Asia Healthcare Holdings ,into how investors assess technology maturity during healthcare diligence. We unpack the difference between hygiene technologies and valuation-accelerating capabilities, and examine how digital infrastructure now influences deal outcomes.

We discuss:

• Which tech capabilities tangibly improve valuation multiples

• How investors assess data maturity, interoperability, and cyber risk

• Why automation is becoming a margin stabiliser

• The linkage between clinical improvement and enterprise value

• The technologies likely to command a premium by 2030

If you are a CEO, CTO, founder, or healthcare investor, this conversation reframes digital strategy as an investment thesis — not an IT roadmap.

What does longevity look like when it’s designed for millions—not just a few?

In this episode, Kristy Berry, CEO of Cenegenics, joins Dr Vikram Venkateswaran on the Healthcare India Podcast to discuss healthspan, behaviour change, data realism, and why longevity must evolve into a scalable platform.

From India’s early chronic disease burden to the ethics of access and trust, the conversation also uncovers an unexpected insight: the spiritual and purpose-driven side of living well, longer.

What happens when five decades of unexplained symptoms collide with the limits of modern medicine?

In this episode of the Healthcare India Podcast, Dr Vikram Venkateswaran speaks with Haresh Patel—entrepreneur, systems thinker, and author of The Ghost in My Body. What begins as a conversation about diagnostic failure, fragmented data, and the blind spots of specialisation evolves into something far deeper.

Drawing on his lived experience of seeing more than a dozen specialists over fifty years, Haresh reframes illness not as a single-diagnosis problem, but as a systems failure—one that medicine is not structurally designed to solve. The discussion explores why healthcare rewards specialisation over synthesis, how longitudinal data and pattern recognition are consistently underused, and why AI must augment—not replace—human intuition.

Unexpectedly, the conversation takes a spiritual turn. Beyond data, technology, and architecture, Dr Vikram finds himself confronting a dimension he did not anticipate—where meaning, awareness, and the human search for coherence intersect with clinical science. The “ghost” turns out to be not just in the body, but in how we understand healing itself.

This episode will resonate with clinicians, founders, technologists, and anyone questioning whether the future of diagnosis lies only in better tools—or in deeper insight.
A conversation that starts with systems thinking and ends by challenging how we define health, certainty, and care.